Clinical trial

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

NCT04654988

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Prednisone Normalized identity: prednisoneView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Azathioprine Normalized identity: azathioprineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Prednisone Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Azathioprine Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-12-01

PhasePHASE4

Conditions

Myocarditisverified · MONDO: myocarditis

Heart Failureverified · MONDO: heart failure

Endomyocardial Biopsyunresolved

Cardiomyopathies, Secondaryunresolved

Immunosuppressionunresolved

Interventions

PrednisoneDRUG · verified · RxNorm: prednisone

AzathioprineDRUG · verified · RxNorm: azathioprine

Placebo PrednisoneDRUG

Placebo AzathioprineDRUG

Sponsors & collaborators

Medical University of Warsawlead sponsor

Mapped research locations

WarsawPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04654988 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.